Stem Cell Therapy in Osteoarthritis: A Step Too Far? Peter M. van der Kraan Current Opinion 09 March 2013 Pages: 175 - 180
The Outlook for Alemtuzumab in Multiple Sclerosis Thomas WilliamsAlasdair ColesLaura Azzopardi Current Opinion 05 April 2013 Pages: 181 - 189
CD6 as a Therapeutic Target in Autoimmune Diseases: Successes and Challenges Mafalda PintoAlexandre M. Carmo Leading Article 09 April 2013 Pages: 191 - 202
Development and Regulation of Biosimilars: Current Status and Future Challenges Asterios S. TsiftsoglouSol RuizChristian K. Schneider Review Article 04 April 2013 Pages: 203 - 211
Regorafenib for Gastrointestinal Malignancies Giuseppe AprileMarianna MacerelliFrancesco Giuliani Review Article 23 February 2013 Pages: 213 - 224
Belimumab Therapy in Systemic Lupus Erythematosus Moncef ZoualiEugene A. Uy Review Article 09 April 2013 Pages: 225 - 235
Gene Therapy for Fabry Disease: A Review of the Literature Aritz Perez Ruiz de GaribayMaría Ángeles SolinísAlicia Rodríguez-Gascón Review Article 11 April 2013 Pages: 237 - 246
Adalimumab: A Review of Its Use in the Treatment of Patients with Ulcerative Colitis Celeste B. BurnessGillian M. Keating Adis Drug Evaluation 12 April 2013 Pages: 247 - 262
Multicomponent Meningococcal Serogroup B Vaccine (4CMenB; Bexsero®): A Review of its Use in Primary and Booster Vaccination Natalie J. Carter Adis Drug Evaluation 11 April 2013 Pages: 263 - 274
Dasatinib: A Guide to Its Use in Chronic Myeloid Leukemia in the EU Gillian M. KeatingKatherine A. Lyseng-WilliamsonSusan J. Keam Adis Drug Clinical Q&A 03 April 2013 Pages: 275 - 279
